Alpha Tau Medical Ltd. financial data

Symbol
DRTS, DRTSW on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
Kiryat Hamada 5, Jerusalem, Israel
State of incorporation
Israel
Fiscal year end
December 31
Latest financial report
Q4 2023 - Mar 7, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 69.7M shares +0.82%
Common Stock, Shares, Outstanding 69.7M shares +0.82%
Weighted Average Number of Shares Outstanding, Basic 69.4M shares +9.2%
Weighted Average Number of Shares Outstanding, Diluted 69.4M shares +9.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 26.4M USD +26.5%
General and Administrative Expense 7.33M USD -28.6%
Operating Income (Loss) -35.7M USD -11%
Nonoperating Income (Expense) 6.54M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -29.1M USD +13.6%
Income Tax Expense (Benefit) 16K USD -20%
Net Income (Loss) Attributable to Parent -29.2M USD +13.6%
Earnings Per Share, Basic -0.42 USD/shares +20.8%
Earnings Per Share, Diluted -0.42 USD/shares +20.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 12.7M USD +117%
Cash, Cash Equivalents, and Short-term Investments 84.9M USD
Assets, Current 85.8M USD -19.5%
Property, Plant and Equipment, Net 12.8M USD +71.3%
Operating Lease, Right-of-Use Asset 8.36M USD +43.9%
Other Assets, Noncurrent 15.1M USD
Assets 107M USD -10.6%
Accounts Payable, Current 2.57M USD +80.3%
Employee-related Liabilities, Current 114K USD +1325%
Accrued Liabilities, Current 2.24M USD +75.2%
Liabilities, Current 7.1M USD +63.7%
Operating Lease, Liability, Noncurrent 6.6M USD +46%
Liabilities 22.9M USD +58.1%
Retained Earnings (Accumulated Deficit) -116M USD -33.7%
Stockholders' Equity Attributable to Parent 84.5M USD -20%
Liabilities and Equity 107M USD -10.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -18M USD +24.8%
Net Cash Provided by (Used in) Financing Activities 5.3M USD -94.5%
Net Cash Provided by (Used in) Investing Activities 18.7M USD
Common Stock, Shares Authorized 362M shares 0%
Common Stock, Shares, Issued 69.7M shares +0.82%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.97M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12.7M USD +89.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 52K USD -78.1%
Deferred Tax Assets, Valuation Allowance 5.84M USD +14.8%
Deferred Tax Assets, Gross 6.95M USD +23.9%
Operating Lease, Liability 7.67M USD
Depreciation 1.07M USD +9.7%
Payments to Acquire Property, Plant, and Equipment 6.4M USD +608%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -29.2M USD +13.6%
Lessee, Operating Lease, Liability, to be Paid 10.7M USD
Property, Plant and Equipment, Gross 15.8M USD +68.4%
Operating Lease, Liability, Current 1.06M USD +58.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.04M USD +69.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.1M USD +59.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +19.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.01M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 899K USD +58.3%
Deferred Tax Assets, Operating Loss Carryforwards 4.37M USD +10.7%
Current Income Tax Expense (Benefit) 16K USD -20%
Lessee, Operating Lease, Liability, to be Paid, Year Four 894K USD +56.6%
Additional Paid in Capital 200M USD +4.15%
Share-based Payment Arrangement, Expense 7.93M USD +17.5%